CompanyDrug

Roche’s Tecentriq Hybreza Becomes First Subcutaneous Anti-PD-(L)1 Immunotherapy in the US

CompanyDrug

Lilly’s Once-Monthly Atopic Dermatitis Treatment Ebglyss Gets Green Light from FDA

CompanyDrug

Roche’s Ocrevus Zunovo Receives FDA Nod as First Twice-Yearly MS Treatment

CompanyDrug

Ascentage Pharma’s Olverembatinib Shows Promise in SDH-Deficient GIST at ESMO Congress

CompanyDeals

Fosun Pharma to Acquire Full Stake in Fosun Kite Biotechnology for USD 27 Million

CompanyDrug

Jiangsu Hengrui’s HER2-Targeted ADC SHR-A1811 Receives Priority Review from China’s NMPA

CompanyDeals

Hangzhou-Based Ophthalmic Device Maker MDCO Secures RMB 200 Million in Series B Funding

CompanyDeals

Beijing Wantai Biological and Fujian Provincial CDC Collaborate on Vaccine Development and Public Health Initiatives

CompanyDeals

MGI Tech and Haihe Laboratory Deepen Collaboration with Introduction of CycloneSEQ-WT02

CompanyDeals

MGI Tech and Sequanta Technologies Launch Advanced DCS Lab to Accelerate Omics Research

Policy / Regulatory

China Boosts Public Health Subsidies and Targets Weight Management in 2024

Policy / Regulatory

China’s NHSA and MOF Issue Notices to Enhance Cross-Regional Medical Treatment Direct Settlement